Neuphoria Therapeutics Inc. (NASDAQ:NEUP) has 21 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| AdvisorShares Investments LLC | 31 Dec, 2025 | 0 | 75,631 | 129.14% | $0.00 |
| Lynx1 Capital Management LP | 31 Dec, 2025 | 0 | 875,228 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Shay Capital LLC | 31 Dec, 2025 | 0 | 169,059 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 4,325 | 33.33% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 60,000 | 0.00% | $0.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 0 | 928 | 5.92% | $0.00 |
| DIADEMA PARTNERS LP | 31 Dec, 2025 | 0 | 28,548 | 133.08% | $0.00 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 14,750 | 0.00% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | 47,443 | 0.00% | $0.00 |
| BOOTHBAY FUND MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 14,000 | 0.00% | $0.00 |
| FNY Investment Advisers, LLC | 31 Dec, 2025 | 0 | 26,500 | 0.00% | $0.00 |
| COMMONWEALTH EQUITY SERVICES, LLC | 31 Dec, 2025 | 0 | 11,207 | 0.00% | $0.00 |
| Persistent Asset Partners Ltd | 31 Dec, 2025 | 0 | 3,587 | 36.54% | $0.00 |
| Merck & Co., Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| XTX Topco Ltd | 31 Dec, 2025 | 0 | 12,008 | 0.00% | $0.00 |
| Tower Research Capital LLC (TRC) | 31 Dec, 2025 | 0 | 990 | 241.46% | $0.00 |
| UBS Group AG | 31 Dec, 2025 | 0 | -516 | -23.80% | $0.00 |
| RHUMBLINE ADVISERS | 31 Dec, 2025 | 0 | 169 | 512.12% | $0.00 |
| Morgan Stanley | 31 Dec, 2025 | 0 | 51 | 728.57% | $0.00 |